Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Other financing activities (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Other financing activities for 3 consecutive years, with $6000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Other financing activities changed N/A to $6000.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $6000.0, a 90.32% decrease, with the full-year FY2023 number at $2.7 million, up 875.27% from a year prior.
  • Other financing activities was $6000.0 for Q1 2025 at Spruce Biosciences, down from $62000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $2.7 million in Q1 2023 to a low of $2000.0 in Q4 2022.
  • A 3-year average of $555800.0 and a median of $50000.0 in 2022 define the central range for Other financing activities.